News

Equillium Announces Multiple Poster Presentations Highlighting EQ504 at the Annual Meeting of The American Association of Immunologists
Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to ...
Siren Biotechnology to Present Universal AAV Immuno-Gene Therapy Data at the 2025 American Society of Gene and Cell Therapy (ASGCT) Annual Meeting
Siren Biotechnology Inc., pioneers of Universal AAV Immuno-Gene Therapy for Cancer, today announced that it will present new ...
TMCnet13h
Alterity Therapeutics Prominently Featured at the International MSA Congress
Presentations will be available on the Alterity Therapeutics website here.
Morningstar6d
Sonoma Biotherapeutics Announces Oral and Poster Presentations at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting
Inc., a clinical-stage biotechnology company developing engineered regulatory T cell (Treg) therapies for autoimmune and inflammatory diseases,will be sharing oral and poster presentations at the ...
Morningstar4d
PDS Biotech Announces Additional Details on Two Preclinical Universal Influenza Presentations at IMMUNOLOGY2025™ Annual Meeting
PRINCETON, N.J., May 08, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq ... presented preclinical data in a poster (#2219) titled, “H3 Hemagglutinin proteins optimized for ...
manilatimes5d
PDS Biotech Announces Additional Details on Two Preclinical Universal Influenza Presentations at IMMUNOLOGY2025™ Annual Meeting
Allen, Ph.D., Program Director/Research Associate, Florida Research and Innovation Center, Cleveland Clinic, presented preclinical data in a poster (#2219 ... comprised of PDS Biotech-licensed ...
Mena FN4d
PDS Biotech Announces Additional Details On Two Preclinical Universal Influenza Presentations At IMMUNOLOGY2025™ Annual Meeting
Allen, Ph.D., Program Director/Research Associate, Florida Research and Innovation Center, Cleveland Clinic, presented preclinical data in a poster ... comprised of PDS Biotech-licensed ...
manilatimes6d
Alterity Therapeutics Announces Multiple Oral and Poster Presentations to be Featured at the International MSA Congress
("Alterity” or "the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that multiple oral and poster presentations ...
Macau Business13h
AAVantgarde presents positive clinical data from its AAVB-081 program for Usher 1B and preclinical data...
AAVantgarde Bio (AAVantgarde), a clinical-stage international biotechnology company with two proprietary Adeno-Associated Viral (AAV) vector platforms for large gene delivery, today announces the ...